PRESS RELEASE published on 08/22/2025 at 09:00, 1 year 1 month ago Original-Research: Nabaltec AG (von NuWays AG): BUY NuWays AG releases a research update on Nabaltec AG, highlighting Q2 results and future prospects, recommending a BUY. Key points include demand trends, improved gross margin, and cash position NuWays AG Investment Recommendation Research Update Q2 Results Nabaltec AG
BRIEF published on 08/21/2025 at 10:05, 1 year 1 month ago Nabaltec AG Reports Decline in First Half of 2025 EBIT Margin Q2 Results Nabaltec AG Investment Plans 2025 Revenue
BRIEF published on 08/21/2025 at 10:05, 1 year 1 month ago Nabaltec AG annonce un déclin au premier semestre 2025 Marge EBIT Nabaltec AG Résultats Du Deuxième Trimestre Plans D'investissement Chiffre D'affaires 2025
PRESS RELEASE published on 08/21/2025 at 10:00, 1 year 1 month ago Nabaltec AG publishes interim report January to June 2025 Nabaltec AG published its interim report January to June 2025, reporting a revenue decrease of 1.7% and EBIT margin of 8.4%. Forecast for 2025: Revenue decline of up to 2% with EBIT margin expected in the range of 7% to 9% EBIT Margin Forecast Revenue Decrease Interim Report Nabaltec AG
BRIEF published on 08/05/2025 at 09:05, 1 year 1 month ago Nabaltec AG Faces Sales Decline Yet Remains Promising Sales Decline Long-term Growth Nabaltec AG Foreign Exchange Aluminum Hydroxide
BRIEF published on 08/05/2025 at 09:05, 1 year 1 month ago Nabaltec AG fait face à une baisse de ses ventes, mais reste prometteuse Baisse Des Ventes Croissance À Long Terme Nabaltec AG Change Hydroxyde D'aluminium
PRESS RELEASE published on 08/05/2025 at 09:00, 1 year 1 month ago Original-Research: Nabaltec AG (von NuWays AG): BUY Nabaltec AG lowers FY25 sales guidance due to FX effect and weaker demand, maintains FY EBIT margin guidance. Q2 sales decrease, but core product demand remains strong. Company offers low valuation and healthy balance sheet Valuation Nabaltec AG Q2 Sales FY25 Sales Guidance Core Product Demand
BRIEF published on 07/24/2025 at 13:44, 1 year 2 months ago Nabaltec AG Revises 2025 Revenue Forecast, Maintains Earnings Outlook EBIT Margin Currency Effects Nabaltec AG Market Uncertainty 2025 Revenue Forecast
BRIEF published on 07/24/2025 at 13:44, 1 year 2 months ago Nabaltec AG révise ses prévisions de chiffre d'affaires pour 2025 et maintient ses perspectives de bénéfices Marge EBIT Nabaltec AG Incertitude Du Marché Effets De Change Prévisions De Revenus Pour 2025
PRESS RELEASE published on 07/24/2025 at 13:39, 1 year 2 months ago EQS-Adhoc: Nabaltec AG adjusts revenue forecast for Financial Year 2025 and confirms earnings forecast Nabaltec AG adjusts revenue forecast for Financial Year 2025 and confirms earnings forecast. Revenues expected to decrease by up to 2% due to currency effects and market uncertainty Revenue Forecast Earnings Forecast Currency Effects Nabaltec AG Financial Year 2025
Published on 10/03/2026 at 02:35, 1 day 17 hours ago Jaguar Health Announces a Special Stock Dividend
Published on 10/02/2026 at 13:50, 2 days 6 hours ago AI/ML Innovations Appoints Lynn Chapman as Chief Financial Officer and Announces Share Issuance for Debt Settlement
Published on 10/02/2026 at 13:00, 2 days 6 hours ago Evergold Drills 4.9 m of 7.70 g/t Au and 186.0 g/t Ag Within 13.5 Metres of 2.84 g/t Au and 127.6 g/t Ag in First 2026 Drill Holes at Golden Lion
Published on 10/02/2026 at 13:00, 2 days 6 hours ago Alaska Energy Metals Appoints Independent Director, Thomas Benson
Published on 10/04/2026 at 06:05, 13 hours 48 minutes ago Blokees Debuts 90+ New Products at Wonder Festival Shanghai 2026
Published on 10/04/2026 at 05:15, 14 hours 38 minutes ago SIBIONICS and PharmaSens Explore New Horizons for Automated Insulin Delivery at EASD 2026
Published on 10/03/2026 at 15:45, 1 day 4 hours ago Huawei Highlights Continuous Innovation, Securing Competitive Edge Through Technological Breakthroughs
Published on 10/02/2026 at 23:55, 1 day 19 hours ago IS SKINCARE GETTING TOO COMPLICATED? CERAVE MAKES THE CASE FOR SAFETY, EFFICACY AND SIMPLICITY
Published on 10/02/2026 at 20:23, 1 day 23 hours ago EQS-Adhoc: Pentixapharm Holding AG: Bafin concludes financial reporting review of the 2024 consolidated financial statements with an error finding
Published on 10/02/2026 at 17:45, 2 days 2 hours ago Information concerning the total number of voting rights and shares 2026 09 30
Published on 10/02/2026 at 17:45, 2 days 2 hours ago Informations relatives au nombre total de droits de vote et d’actions 2026 09 30
Published on 10/02/2026 at 17:35, 2 days 2 hours ago Peugeot Invest - Déclaration du nombre d'actions et de droits de vote
Published on 10/02/2026 at 17:30, 2 days 2 hours ago Aéroports de Paris SA - Calendrier financier 2027
